1. Home
  2. LION vs NVAX Comparison

LION vs NVAX Comparison

Compare LION & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • NVAX
  • Stock Information
  • Founded
  • LION 1997
  • NVAX 1987
  • Country
  • LION United States
  • NVAX United States
  • Employees
  • LION N/A
  • NVAX N/A
  • Industry
  • LION Movies/Entertainment
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LION Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • LION Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LION 1.6B
  • NVAX 1.3B
  • IPO Year
  • LION N/A
  • NVAX 1995
  • Fundamental
  • Price
  • LION $5.72
  • NVAX $6.84
  • Analyst Decision
  • LION Strong Buy
  • NVAX Buy
  • Analyst Count
  • LION 6
  • NVAX 5
  • Target Price
  • LION $9.58
  • NVAX $16.60
  • AVG Volume (30 Days)
  • LION 2.1M
  • NVAX 4.9M
  • Earning Date
  • LION 08-07-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • LION N/A
  • NVAX N/A
  • EPS Growth
  • LION N/A
  • NVAX N/A
  • EPS
  • LION N/A
  • NVAX 2.97
  • Revenue
  • LION $3,947,900,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • LION N/A
  • NVAX $56.85
  • Revenue Next Year
  • LION $7.02
  • NVAX N/A
  • P/E Ratio
  • LION N/A
  • NVAX $2.30
  • Revenue Growth
  • LION N/A
  • NVAX 25.92
  • 52 Week Low
  • LION $5.55
  • NVAX $5.01
  • 52 Week High
  • LION $8.50
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • LION 39.97
  • NVAX 51.12
  • Support Level
  • LION $5.55
  • NVAX $6.54
  • Resistance Level
  • LION $5.86
  • NVAX $7.20
  • Average True Range (ATR)
  • LION 0.19
  • NVAX 0.28
  • MACD
  • LION 0.02
  • NVAX 0.06
  • Stochastic Oscillator
  • LION 26.76
  • NVAX 66.36

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: